Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
Sitting Down With... Fiona Greer, a biosimilar guru from SGS.
Could manufacturers based in Russia be well placed to develop cheaper biopharmaceuticals?
We investigate the advantages and limitations of microcalorimetry in biopharma.
How inspiration from the airline industry could help improve the biosimilars industry.
Biosimilar drugmakers should remember that the best cake is one that doesn't have to be shared.
Our infographic shows how much can be saved with generic drugs
Eva McLellan and Martyn Smith
The players and chips are ready, what can poker teach us about the biosimilars business?
Sitting Down With... Carol Lynch, Global Head Biopharmaceuticals, Sandoz.
Are reduced GDUFA fees on the horizon for contract manufacturers?
This article explains how an inline probe was used to monitor a granulation at three different scales to confirm that, in each case, the granules produced were the same size, and more importantly produced tablets of identical quality as quantified by hardness.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Every Disease Has its Day
The Cutting Edge of Biopharma Analytics
It’s All About Connecting